April 07, 2026 04:41 pm (IST)
Jubilant Life Sciences receives ANDA approval for Levofloxacin Tablets
New Delhi, June 23 (IBNS) Jubilant Life Sciences Ltd, an integrated global Pharmaceuticals and Life Sciences Company, has received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration (US FDA) for Levofloxacin Tablets, 250mg and 500mg, the generic version of Levaquin Tablets (of Ortho-McNeil), which is used for the treatment of adults with infections such as pneumonia, bacterial sinusitis, chronic bronchitis, skin and skin structure infections, chronic bacterial prostatitis, urinary tract infections and inhalational anthrax.
The total market size for Levofloxacin Tablets as per IMS is $28 Million per annum.
As on Mar 31, Jubilant Life Sciences had a total of 806 filings for formulations of which 368 have been approved in various regions globally. This includes 72 ANDAs filed in the US, of which 38 have been approved and 46 Dossier filings in Europe.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Air India CEO Campbell Wilson quits amid losses, regulatory heat after deadly Ahmedabad crash: Report
Tue, Apr 07 2026
No panic, no stress: Fired from Oracle, techie returns home, drives Uber — Now his story is going viral
Mon, Apr 06 2026
Wipro gains 3% on long-term deal with Olam Group
Mon, Apr 06 2026
Senco Gold jumps 11% on business update; jewellery stocks advance
Mon, Apr 06 2026
Nykaa shares rise 4% after Q4 business update
Mon, Apr 06 2026
Trent shares gain 6% after robust Q4; revenue rises 20% YoY
Mon, Apr 06 2026
No fuel, LPG crisis! HPCL assures uninterrupted supply across India
Sun, Apr 05 2026
HDB Financial Services and Amazon Web Services bring together brightest minds to solve critical fintech challenges in India
Fri, Apr 03 2026
Nissan Motor India domestic sales surge 98 pct MoM in March 2026
Fri, Apr 03 2026
